Hot Features
Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with A... Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026. The company was incorporated in 2013 and is headquartered in Vancouver, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.44 | -20.7547169811 | 2.12 | 2.25 | 1.28 | 270413 | 1.5530281 | CS |
| 4 | -0.43 | -20.3791469194 | 2.11 | 3 | 1.28 | 192835 | 2.09555745 | CS |
| 12 | -0.52 | -23.6363636364 | 2.2 | 3 | 0.8 | 99125 | 1.93062295 | CS |
| 26 | 1.505 | 860 | 0.175 | 3 | 0.175 | 66324 | 1.86429911 | CS |
| 52 | 1.505 | 860 | 0.175 | 3 | 0.175 | 66324 | 1.86429911 | CS |
| 156 | 1.505 | 860 | 0.175 | 3 | 0.175 | 66324 | 1.86429911 | CS |
| 260 | 1.505 | 860 | 0.175 | 3 | 0.175 | 66324 | 1.86429911 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.